Rapidly increasing maternal morbidity and death continue to be mostly attributed to cardiovascular disease. Whenever both the pregnant woman and the developing foetus are exposed to several possible difficulties, various physiological changes of gestation happen. Women who have pre-existing cardiac conditions, such as congenital abnormalities, angina pectoris, coronary artery disease and aortopathies, need to undergo multidisciplinary testing, counselling, and optimization before getting pregnant. They also need to be closely monitored and have their medication needs managed. Close monitoring is crucial for patients who developed cardiac conditions like congestive heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The signs of a cardiac issue during pregnancy include- fatigue, chest pain, shortness of breath, fainting, difficulty breathing while sleeping.
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Back to basics: The pharmacokinetics of direct oral anticoagulants in short-gut syndrome
Abhishek Chandra, Abbott Northwestern Hospital, United States
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia